Journal
JOURNAL OF OVARIAN RESEARCH
Volume 2, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/1757-2215-2-13
Keywords
-
Categories
Funding
- Cancer Treatment Centers of America Register Trademark
Ask authors/readers for more resources
CA125 is the gold standard tumor marker in ovarian cancer. Serum level of CA125 is used to monitor response to chemotherapy, relapse, and disease progression in ovarian cancer patients. Thus, it is reasonable to investigate whether CA125 may have utility as a prognostic indicator as well in ovarian cancer. A large number of epidemiological studies have been carried out to this effect. This review summarizes all available epidemiological literature on the association between CA125 levels and survival in ovarian cancer. To place these studies in context, we provide some background information on CA125 and its role in ovarian cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available